3-Year Study Confirms Favorable Safety & Tolerability Profile of REMFresh Melatonin
REMSU36 captured and analyzed serious and non-serious adverse event reports, and no serious adverse events were reported.
REMSU36 captured and analyzed serious and non-serious adverse event reports, and no serious adverse events were reported.
A patient-reported outcomes study presented at SLEEP 2018 provides confirmatory real-world...